[
    [
        {
            "time": "2020-04-15",
            "original_text": "Innovent and Eli Lilly Announce NMPA Acceptance of a Supplemental New Drug Application for Sintilimab in Combination with ALIMTA® (Pemetrexed) and Platinum as First-Line Therapy in Non-squamous NSCLC",
            "features": {
                "keywords": [
                    "NMPA",
                    "Sintilimab",
                    "ALIMTA",
                    "NSCLC"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "Innovent and Eli Lilly Announce NMPA Acceptance of a Supplemental New Drug Application for Sintilimab in Combination with ALIMTA® (Pemetrexed) and Platinum as First-Line Therapy in Non-squamous NSCLC",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-04-16",
            "original_text": "Stocks Give Up Gains After Negative Report on Coronavirus Drug",
            "features": {
                "keywords": [
                    "Stocks",
                    "Gains",
                    "Negative Report",
                    "Coronavirus Drug"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Stocks Give Up Gains After Negative Report on Coronavirus Drug",
                "Correlation": 6,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-04-17",
            "original_text": "Stock market news live updates: Stocks end little changed after report Gilead's virus treatment disappoints in trial",
            "features": {
                "keywords": [
                    "Stock Market",
                    "Gilead",
                    "Virus Treatment",
                    "Trial"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Stock market news live updates: Stocks end little changed after report Gilead's virus treatment disappoints in trial",
                "Correlation": 7,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-04-18",
            "original_text": "Why The Coronavirus Pandemic Isn't Shaking This Red-Hot Pharma Stock",
            "features": {
                "keywords": [
                    "Coronavirus",
                    "Pharma Stock"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Why The Coronavirus Pandemic Isn't Shaking This Red-Hot Pharma Stock",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-04-19",
            "original_text": "Negative Report on Gilead Sciences’ Coronavirus Drug Hits Stocks",
            "features": {
                "keywords": [
                    "Negative Report",
                    "Gilead Sciences",
                    "Coronavirus Drug"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Negative Report on Gilead Sciences’ Coronavirus Drug Hits Stocks",
                "Correlation": 8,
                "Sentiment": 2,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-04-20",
            "original_text": "Lilly Shares Reach Record After Drugmaker Moves Fast on Virus",
            "features": {
                "keywords": [
                    "Lilly Shares",
                    "Record",
                    "Drugmaker",
                    "Virus"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Lilly Shares Reach Record After Drugmaker Moves Fast on Virus",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-04-21",
            "original_text": "Eli Lilly Q1 Earnings Beat, Coronavirus May Mar Profits",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Q1 Earnings",
                    "Coronavirus",
                    "Profits"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Eli Lilly Q1 Earnings Beat, Coronavirus May Mar Profits",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-04-22",
            "original_text": "Eli Lilly Smashes Q1 Earnings Forecast as Trulicity Sales Surge; Boosts 2020 Profit Guidance",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Q1 Earnings",
                    "Trulicity Sales",
                    "Profit Guidance"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Eli Lilly Smashes Q1 Earnings Forecast as Trulicity Sales Surge; Boosts 2020 Profit Guidance",
                "Correlation": 10,
                "Sentiment": 10,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-04-23",
            "original_text": "Eli Lilly lifts 2020 profit forecast; coronavirus fuels stockpiling of its medicines",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Profit Forecast",
                    "Coronavirus",
                    "Stockpiling"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Eli Lilly lifts 2020 profit forecast; coronavirus fuels stockpiling of its medicines",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-04-24",
            "original_text": "Dow futures edge back as investors await report that could show total unemployed in U.S. tops 25 million",
            "features": {
                "keywords": [
                    "Dow Futures",
                    "Investors",
                    "Unemployed",
                    "U.S."
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "economy"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Dow futures edge back as investors await report that could show total unemployed in U.S. tops 25 million",
                "Correlation": 5,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 10,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]